What other stocks do shareholders of iSignthis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iSignthis investors own include PolyNovo (PNV) , Paradigm Biopharmaceuticals (PAR) , Novo Resources Corp. (NVO.V) (NVO) , Nearmap (NEA) , Argent BioPharma (MXC) , Medlab Clinical (MDC) , Bod Australia (BDA) , AVITA Medical (AVH) , Alcidion Group (ALC) and AusCann Group (AC8) .

ASX:ISX

iSignthis (ISX) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free ISX Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 20.04 million shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get iSignthis alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About iSignthis Stock (ASX:ISX)

iSignthis Ltd, together with its subsidiaries, engages in remote identity verification, and payment authentication and processing activities in Australia, Europe, and British Virgin Islands. Its solutions include Paydentity, a solution that incorporates payment instrument verification and customer identification to remotely link an electronic payment with a person's identity for satisfying anti money laundering and counter terrorism financing regulatory requirements; and ISXPay, a solution, which provides a range of gateway, risk management and avoidance, and processing services for card transactions and alternative payment methods. iSignthis Ltd was founded in 2013 and is headquartered in Melbourne, Australia.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

ISX Stock News Headlines

September 21, 2023 | investing.com

ISX Main 60 Historical Data

August 24, 2023 | afr.com

White collar crime

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

July 29, 2023 | afr.com

Max Mason

June 27, 2023 | afr.com

iSignthis boss misled market on revenues: ASIC

June 26, 2023 | afr.com

Visa termination letter wasn’t a final decision, iSignthis says

June 8, 2023 | afr.com

Experts clash over market expectations of iSignthis

June 7, 2023 | afr.com

iSignthis boss ‘lying’ about Visa termination: court

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

June 6, 2023 | afr.com

iSignthis inflated revenue to get share bonus, court told

March 3, 2023 | afr.com

iSignthis chairman says market was informed about big contracts

March 2, 2023 | afr.com

Visa termination would not have hurt iSignthis shares, court hears

March 1, 2023 | afr.com

Accounting standards made us do it, iSignthis tells court

February 28, 2023 | afr.com

Court hears iSignthis boss John Karantzis misled investors

January 10, 2023 | investing.com

ISX Main 60 (ISX60)

December 15, 2022 | afr.com

John Karantzis gets Grinched

December 1, 2022 | afr.com

John Karantzis: amateur historian

November 2, 2022 | afr.com

John Karantzis must be taken at his word

October 6, 2022 | fool.com.au

Why the iSignthis share price stormed 12% higher today

September 23, 2022 | reuters.com

Asiacell Communications PJSC

August 28, 2022 | afr.com

iSignthis’ ASX lawsuit stalls over unpaid bond

August 21, 2022 | fool.com.au

Why iSignthis shares stormed 21% higher to an all-time high today

August 16, 2022 | fool.com.au

iSignthis share price up 146% this year but down 4% today, what happened?

August 14, 2022 | afr.com

iSignthis ensnared in giant cannabis Ponzi collapse

August 10, 2022 | fool.com.au

Why the iSignthis share price is up 350% in 2019

April 7, 2022 | afr.com

John Karantzis has his legal fees covered

February 28, 2022 | au.finance.yahoo.com

iSignthis Ltd (ISX.AX) 2021 Financial Statements

See More Headlines

Receive ISX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSignthis and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Computer and Technology
Industry: Software - Application
Sub-Industry: N/A
Current Symbol: ASX:ISX
CUSIP: N/A
CIK: N/A
Web: www.isignthis.com
Phone: 61 3 8640 0990
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 8.22
Current Ratio: 1.18
Quick Ratio: 0.20

Sales & Book Value

Annual Sales: $43.61 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 102.78
Book Value: A$0.02 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 1,097,229,952
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Mr. Nickolas John Karantzis
MD, CEO & Exec. Director
Mr. Todd Richards B.Bus
CPA, CFO & Company Sec.
Mr. Andrew Karantzis
Global Sales & Marketing Director

Key Competitors

View All Competitors

ISX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of iSignthis own?: Based on aggregate information from My MarketBeat watchlists, some companies that other iSignthis investors own include PolyNovo (PNV), Paradigm Biopharmaceuticals (PAR), Novo Resources Corp. (NVO.V) (NVO), Nearmap (NEA), Argent BioPharma (MXC), Medlab Clinical (MDC), Bod Australia (BDA), AVITA Medical (AVH), Alcidion Group (ALC) and AusCann Group (AC8).

This page (ASX:ISX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

iSignthis (ISX) Stock Price, News & Analysis

About iSignthis Stock (ASX:ISX)

ISX Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

ISX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info